Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
10.13
+0.48 (4.97%)
Nov 22, 2024, 4:00 PM EST - Market closed

Avalo Therapeutics Statistics

Total Valuation

AVTX has a market cap or net worth of $106.00 million. The enterprise value is $27.43 million.

Market Cap 106.00M
Enterprise Value 27.43M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

AVTX has 10.46 million shares outstanding. The number of shares has increased by 2,315.84% in one year.

Current Share Class 10.46M
Shares Outstanding 10.46M
Shares Change (YoY) +2,315.84%
Shares Change (QoQ) -53.89%
Owned by Insiders (%) 5.26%
Owned by Institutions (%) 18.53%
Float 4.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 25.57
Forward PS n/a
PB Ratio 4.65
P/TBV Ratio 10.02
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 33.45
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.07.

Current Ratio 1.42
Quick Ratio 1.37
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -42.52% and return on invested capital (ROIC) is -95.33%.

Return on Equity (ROE) -42.52%
Return on Assets (ROA) -30.64%
Return on Capital (ROIC) -95.33%
Revenue Per Employee $43,158
Profits Per Employee -$428,158
Employee Count 19
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax -9,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -53.10% in the last 52 weeks. The beta is 1.03, so AVTX's price volatility has been similar to the market average.

Beta (5Y) 1.03
52-Week Price Change -53.10%
50-Day Moving Average 11.08
200-Day Moving Average 10.53
Relative Strength Index (RSI) 37.71
Average Volume (20 Days) 59,907

Short Selling Information

The latest short interest is 10,057, so 0.10% of the outstanding shares have been sold short.

Short Interest 10,057
Short Previous Month 49,242
Short % of Shares Out 0.10%
Short % of Float 0.24%
Short Ratio (days to cover) 0.33

Income Statement

In the last 12 months, AVTX had revenue of $820,000 and -$8.14 million in losses. Loss per share was -$75.46.

Revenue 820,000
Gross Profit -9.34M
Operating Income -31.31M
Pretax Income -142.87M
Net Income -8.14M
EBITDA -31.17M
EBIT -31.31M
Loss Per Share -$75.46
Full Income Statement

Balance Sheet

The company has $81.86 million in cash and $1.63 million in debt, giving a net cash position of $80.23 million or $7.67 per share.

Cash & Cash Equivalents 81.86M
Total Debt 1.63M
Net Cash 80.23M
Net Cash Per Share $7.67
Equity (Book Value) 22.73M
Book Value Per Share 2.18
Working Capital 25.47M
Full Balance Sheet

Cash Flow

Operating Cash Flow -36.78M
Capital Expenditures n/a
Free Cash Flow -36.78M
FCF Per Share -$3.51
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -3,818.41%
Pretax Margin -971.59%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -1,850.34%

Dividends & Yields

AVTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2,315.84%
Shareholder Yield -2,315.84%
Earnings Yield -7.67%
FCF Yield -34.70%

Analyst Forecast

The average price target for AVTX is $35.00, which is 245.51% higher than the current price. The consensus rating is "Buy".

Price Target $35.00
Price Target Difference 245.51%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 29, 2023. It was a reverse split with a ratio of 0.0041667:1.

Last Split Date Dec 29, 2023
Split Type Reverse
Split Ratio 0.0041667:1

Scores

AVTX has an Altman Z-Score of -5.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.32
Piotroski F-Score n/a